arrow
D

Deepak Sundriyal

department of medical oncology hematology
H指数:11
被引数:418

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world efficacy and safety of trastuzumab emtansine biosimilar (UJVIRA®) in early and metastatic HER2-positive breast cancer: a multicenter pooled retrospective analysis from India

曲妥珠单抗emtansine生物类似物(UJVIRA®)在早期和转移性HER2阳性乳腺癌中的真实世界疗效与安全性:一项来自印度的多中心合并回顾性分析

2026-10-280
PRE
Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India

PARP抑制剂在BRCA突变或HRD阳性晚期卵巢癌一线维持治疗中的真实世界数据:一项来自印度的多中心回顾性研究

2026-02-070
OAAI
Clinicopathological profile and outcomes of neuroendocrine tumors: Data from a multicenter collaborative registry in India

神经内分泌肿瘤的临床病理特征与预后:来自印度多中心协作登记研究的资料

2024-12-010
PRE
Real-world data of PARP inhibitors in first-line maintenance for BRCA mutated or HRD positive advanced ovarian cancer: A multicenter retrospective study from India

PARP抑制剂在BRCA突变或HRD阳性晚期卵巢癌一线维持治疗中的真实世界数据:一项来自印度的多中心回顾性研究

2024-12-010
PRE
Clinicopathologic Profile and Treatment Outcomes of Colorectal Cancer in Young Adults: A Multicenter Study From India
2024-05-012
PRE
An assessment of childhood cancer care services in India - gaps, challenges and the way forward
2023-09-013
OAAI